Gracell Biotechnologies to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference

Rhea-AI Summary

Gracell Biotechnologies Inc. (NASDAQ: GRCL) announced its participation in the Piper Sandler 33rd Annual Virtual Healthcare Conference from November 29th to December 2nd, 2021. The management team will hold a fireside chat starting November 22nd, available on demand, and will conduct virtual investor meetings on December 1st and 2nd. A webcast of the chat will be accessible for 90 days on the Company's website. Gracell is focused on developing affordable cell therapies for cancer, utilizing its FasTCAR and TruUCAR technology platforms.

SUZHOU, China and PALO ALTO, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that the management team will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference from November 29^th to December 2^nd.

The Gracell team is scheduled to hold a fireside chat that will be available on demand starting on November 22^nd and will host virtual investor meetings at the conference on December 1^st and 2^nd.

A webcast of the fireside chat will be available on the "Events and Presentations" page of the Investors section of the Company's website. A replay of the webcast will be available for 90 days following the event. For more information, please visit ir.gracellbio.com.

About Gracell

Gracell Biotechnologies Inc. ("Gracell") is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. Leveraging its pioneering FasTCAR and TruUCAR technology platforms, Gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the potential to overcome major industry challenges that persist with conventional CAR-T therapies, including lengthy manufacturing time, suboptimal production quality, high therapy cost and lack of effective CAR-T therapies for solid tumors. For more information on Gracell, please visit www.gracellbio.com

Follow @GracellBio on LinkedIn

Media contact

Marvin Tang

marvin.tang@gracellbio.com

Investor contact

Gracie Tong

gracie.tong@gracellbio.com

FAQ

What event will Gracell Biotechnologies participate in?

Gracell Biotechnologies will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference from November 29th to December 2nd, 2021.

When is the Gracell fireside chat available?

The Gracell fireside chat will be available on demand starting November 22nd, 2021.

What dates are the virtual investor meetings hosted by Gracell?

Gracell will host virtual investor meetings on December 1st and 2nd, 2021.

Where can I find the webcast of Gracell's fireside chat?

The webcast of Gracell's fireside chat can be found on the 'Events and Presentations' page of the Company's website.

What technologies does Gracell utilize for cancer therapies?

Gracell utilizes FasTCAR and TruUCAR technology platforms to develop cell therapies for cancer treatment.